Acri Capital Acquisition Corporation Announces Confidential Submission of Draft Registration Statement on Form S-4 and Extension of the Deadline for an Initial Business Combination
April 10, 2024 16:30 ET
|
Acri Capital Acquisition Corporation
Austin, Texas, April 10, 2024 (GLOBE NEWSWIRE) -- Acri Capital Acquisition Corporation (the “Company”) (Nasdaq: ACAC), a special purpose acquisition company, today announced that, in relation to its...
BioElectronics Corporation Announces the Publication of a Canine Arthritis Study
March 25, 2024 08:45 ET
|
BioElectronics Corporation
96% of the Dogs Treated With the Active Model 088 Device Showed Marked Improvement FREDERICK, MD, March 25, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioElectronics Corporation...
Acri Capital Acquisition Corporation Announces Extension of the Deadline for an Initial Business Combination
March 13, 2024 16:05 ET
|
Acri Capital Acquisition Corporation
Austin, Texas, March 13, 2024 (GLOBE NEWSWIRE) -- Acri Capital Acquisition Corporation (the “Company”) (Nasdaq: ACAC), a special purpose acquisition company, today announced that, in order to extend...
BioElectronics Corporation Announces the Publication of Pilot Study Results
February 23, 2024 08:30 ET
|
BioElectronics Corporation
Beneficial Treatment Effect for Phantom and Residual Limb Pain Identified FREDERICK, MD, Feb. 23, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – BioElectronics Corporation (https://www.bielcorp.com/...
BioElectronics Chairman Updates Investors
February 15, 2024 09:00 ET
|
BioElectronics Corporation
Discusses Clinical Trial Progress and Potential Legal Action Against MundiPharma FREDERICK, MD, Feb. 15, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – BioElectronics Corporation...
NeuroSigma Announces FDA Clearance of its Second-Generation Monarch eTNS System for Treating Pediatric ADHD
January 18, 2024 00:21 ET
|
NeuroSigma, Inc.
LOS ANGELES, Jan. 17, 2024 (GLOBE NEWSWIRE) -- NeuroSigma today announced that the U.S. Food and Drug Administration (FDA) cleared use of NeuroSigma’s second-generation Monarch eTNS System for...
NeuroSigma Announces FDA 510(k) Submission for Second Generation Monarch eTNS System
November 07, 2023 08:50 ET
|
NeuroSigma, Inc.
LOS ANGELES, Nov. 07, 2023 (GLOBE NEWSWIRE) -- NeuroSigma today announced it has submitted a 510(k) premarket notification to the U.S. Food and Drug Administration (FDA) for its second-generation...
NeuroSigma Announces HSA Approval of the Monarch eTNS System in Singapore
October 03, 2023 09:00 ET
|
NeuroSigma, Inc.
LOS ANGELES, Oct. 03, 2023 (GLOBE NEWSWIRE) -- NeuroSigma today announced approval of the Monarch eTNS System by Singapore’s Health Sciences Authority (HSA), the national body that regulates medical...
Bioelectronics Market Size 2023 is Bound To Make An Impact Business Trend, Sales Potential, Opportunities with Strategic Growth 2029
September 21, 2023 06:15 ET
|
Market Reports World
Pune, Sept. 21, 2023 (GLOBE NEWSWIRE) -- Global Bioelectronics Market [2023-2029] Research Report Analysis and Outlook Insights | Latest Updated Report | 106 Pages Report | The Bioelectronics Market...
41% of U.S. Workers Say They are Most Productive Outside of 9-5 Work Hours, According to Research from Fiverr
September 19, 2023 08:00 ET
|
Fiverr International Ltd.
NEW YORK, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Fiverr International Ltd. (NYSE: FVRR), the company that is revolutionizing how the world works together, has compiled findings from a study exploring...